- Cefotetan
drugbox
IUPAC_name = (7"S")-7-{ [4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)
1,3-dithietane-2-carbonyl] amino}-7-methoxy-
3- [(1-methyltetrazol-5-yl)sulfanylmethyl] -8-oxo-
5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid
width = 250
CAS_number = 69712-56-7
ATC_prefix = J01
ATC_suffix = DC05
PubChem = 50614
DrugBank =
C = 17 | H = 17 | N = 7 | O = 8 | S = 4
molecular_weight = 575.623 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Cefotetan is an injectable
antibiotic of thecephamycin type for prophylaxis and treatment ofbacterial infection s. It is often grouped together with second-generationcephalosporin s and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.Cefotetan was developed by Yamanouchi. It is marketed outside Japan by
AstraZeneca with the brand names Apatef and Cefotan.External links
* [http://www.cefotan.com/content/products/productDisplay.asp?id=32 Cefotan official web site] run by
AstraZeneca US
* [http://www.rxlist.com/cgi/generic2/cefotet.htm Cefotetan] entry in RxList
Wikimedia Foundation. 2010.